CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

padsevonil

Small moleculeexperimental

Clinical trial activity

15 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
10
Phase 2
4
Phase 3
2
Phase 4
0

Earliest trial started Jul 1, 2015 (NCT02495844)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2017

    Earliest Phase 1 Sponsor(trial)

  3. Jan 1, 2019

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

COCc1nn2c(CN3C[C@@H](CC(F)(F)Cl)CC3=O)c(C(F)(F)F)nc2s1
Mol. weight
432.8 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • ucb0942

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04283136Phase 1Feb 24, 2020UCB
NCT04136444Phase 1Oct 31, 2019UCB
NCT04131517Phase 1Oct 31, 2019UCB
NCT04126343Phase 1Oct 31, 2019UCB
NCT04075409Phase 1Oct 31, 2019UCB
NCT04039919Phase 1Aug 31, 2019UCB
NCT04013191Phase 1Jul 31, 2019UCB
NCT03739840Phase 3Mar 6, 2019UCB
NCT03695094Phase 1Sep 18, 2018UCB
NCT03370120Phase 2/Phase 3 (Phase 3)Aug 27, 2018UCB
NCT03480243Phase 1Mar 27, 2018UCB
NCT03373383Phase 2Feb 12, 2018UCB
NCT03168984Phase 1May 5, 2017Hoosier Cancer Research Network
NCT02625090Phase 2Sep 1, 2015Hoosier Cancer Research Network
NCT02495844Phase 2Jul 1, 2015Hoosier Cancer Research Network, Pharmaceutical Research Associates, Inc. (PRA)
Showing 15 of 15 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
UCBFor profit121232018
Hoosier Cancer Research NetworkAcademic/Hospital3322015
Pharmaceutical Research Associates, Inc. (PRA)For profit1012015
3 organizations
Page 1 / 1